Latest news
New drug could mean less frequent injections
Posted: Tuesday 21 November 2017
Results from a recent clinical trial suggest that a possible new treatment for wet age-related macular degeneration (AMD) could control symptoms as effectively as current treatments, with less frequent injections.The late-stage trials have revealed the d…
Find out more
Petition reaches more than 11,000 signatures
Posted: Monday 20 November 2017
More than 11,000 people signed our petition to end needless sight loss, after a Macular Society volunteer was forced to invade the headquarters of his local healthcare commissioners when he experienced delays to treatment.Chris Thorley waited more than n…
Find out more
Charles Bonnet Awareness Day
Posted: Tuesday 14 November 2017
As part of our Charles Bonnet campaign, which launched last month, we encouraged people to talk openly about their hallucinations.Today, to mark Charles Bonnet Awareness Day
Find out more
Coming up in winter’s Sideview
Posted: Tuesday 14 November 2017
The latest issue of Sideview magazine will be sent out to 22,000 Macular Society members in late November.
Find out more
FDA investigate potential Stargardt treatment
Posted: Monday 13 November 2017
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a drug to help treat Stargardt disease, according to Lin BioScience.The drug, known as LBS-008, is designed to prevent the build-up of a toxin in the eye called lipofuscin…
Find out more
Do you want a place in the London Marathon?
Posted: Wednesday 8 November 2017
Have you always wanted to run the London Marathon but struggled to get a place?Now could be your chance to do just that, while raising vital funds for people with macular disease.The Macular Society has a coveted place in next year’s race and is calling …
Find out more
Eylea approved for myopic CNV patients
Posted: Wednesday 1 November 2017
The National Institute of Health and Care Excellence (NICE) has recommended the use of Eylea® on adults for treating visual impairment due to myopic chorodial neovascularisation (CNV).Pathological myopia, also known as severe near sightedness, affects 3%…
Find out more
Drug companies threaten legal fight over cheaper drug
Posted: Wednesday 1 November 2017
Health chiefs face a legal fight over plans to give a cheap drug to patients with wet age-related macular degeneration (AMD).
Find out more
Simplyhealth funds counselling service for people with sight loss
Posted: Tuesday 31 October 2017
Simplyhealth has donated £30,000 to the Macular Society to help people with macular disease gain access to vital counselling services.The Macular Society, the national sight loss charity, offers free telephone counselling by accredited counsellors which …
Find out more
Eye bank levels fall below level needed
Posted: Monday 30 October 2017
NHS Blood and Transplant (NHSBT) has revealed that its eye banks are 21% below the level needed to supply hospitals, leading to delays in cornea transplant operations.At the end of September, there were 278 corneas in the service’s Manchester and Bristol…
Find out more
Your questions answered
Posted: Thursday 26 October 2017
On Monday we ran out of time to ask all of your questions as part of our Charles Bonnet Twitter Q&A.
Find out more
Charles Bonnet Q&A
Posted: Monday 23 October 2017
As part of our Charles Bonnet campaign, Dr John-Paul Taylor, Clinical Senior Lecturer and Consultant from the Newcastle University took part in a live Twitter question and answer session.If you were unable to join the session, please find the full Q&A; s…
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter
